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Objective: Failed back surgery syndrome is characterized by the presence of intractable pain 
and varying degrees of functional incapacity after lumbar spine surgery. Because the mechanisms 
that cause pain are variable, treatment of this syndrome is quite difficult, and one of the most 
common methods that is used for treatment nowadays is epidural injection. This research 
evaluates the analgesic efficacy of addition of oral gabapentin treatment to epidural corticosteroid 
application in patients with failed back surgery syndromes.
Methods: Forty-two patients, including 23 females and 19 males, with failed back surgery 
syndrome who had been previously operated on at least twice due to lumbar disc herniation 
were randomly divided into two groups. Following epidural application of a single dose of 
methylprednisolone in the first group of patients (Group K), an oral medical treatment contain-
ing naproxen sodium, tizanidine, and vitamin B and C complex, was devised to be applied for 
one month. For the second group, oral gabapentin was added to the same treatment regime 
(Group G). Pain levels were evaluated by a visual analog scale for straight leg raise before, 
during, and after treatment, as well as in the first and third months.
Results: There was no demographically significant difference between the patients (P . 0.05). 
After the beginning of treatment, it was observed that the pain level in Group G patients 
regressed earlier and that it progressed at a significantly lower level (both in the first and third 
month controls).
Conclusion: It was concluded that addition of oral gabapentin to epidural corticosteroid 
application in patients with failed back surgery syndromes was effective in ameliorating pain 
at an early stage without significant side effects.
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Introduction
Luschka was the first to describe degeneration and prolapse of the intervertebral disc 
in 1858. Later, in 1909, Krause and Oppenheim performed the first successful surgical 
excision of a herniated intervertebral disc.1 In 1934, Mixter and Barr demonstrated that 
a herniated disc could cause nerve root encroachment, ultimately producing back pain. 
The removal of the disc did not always result in pain relief. In 1951, Barr decided that 
a patient may have persistent low back pain, sciatica, or both, despite surgical inter-
vention.2 The evolved definition of failed back surgery syndrome (FBSS) is persistent 
or recurring low back pain, with or without sciatica following one or more lumbar 
operations.3 In the literature, the frequency of its occurrence is 1%–48%.4–9
Epidural fibrosis is among the most common causes of FBSS, and is often refractory 
to treatment.10 Repeated surgery for fibrosis has only a 30%–35% success rate, and Clinical Pharmacology:   Advances and Applications 2010:2 submit your manuscript | www.dovepress.com
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15%–20% of patients report worsening of their symptoms.10 
The causes of epidural fibrosis include surgical manipulation 
of tissue at the time of surgery, bleeding, dural tears, and 
irritation from mechanical instability.10
Phospholipase A2, the rate-limiting enzyme in the conver-
sion of arachidonic acid to prostaglandins and leukotrienes, 
has been found in high levels in discs removed at discectomy,11 
and has been implicated as a primary inflammatory mediator 
and a cause for peripheral nerve injury.12 Corticosteroids are 
known to inhibit prostaglandin synthesis, impair both cell-
mediated and humoral immune responses, stabilize cellular 
membranes, and block nociceptive C-fiber conduction.13–18
Gabapentin is a structural analog of γ-aminobutyric acid 
and acts at the α2δ1 subunits of voltage-dependent calcium 
channels. It can act via primary afferent neurons, dorsal 
root ganglia, dorsal horn neurons, and supraspinal sites.19 
Gabapentin was found to be effective in animal models of 
postoperative, inflammatory, and/or neuropathic pain. It 
has also been found in animal experiments that gabapentin 
decreases movement-associated responses in neuropathic 
pain and in peripheral inflammation.20
This study compared the analgesic efficacy of adding of 
oral gabapentin treatment to epidural corticosteroid applica-
tion in patients with FBSS.
Method
This study was conducted at a university hospital, and 
the protocol was approved by the hospital’s institutional 
review board. The participants in this study were recruited 
in a consecutive manner from referrals to one private 
practice affiliated with the hospital. Patients were eligible 
to participate in this study if they were older than 18 years, 
had primarily leg pain more than back pain, had been 
symptomatic for longer than six weeks, had undergone 
a lumbar spine magnetic resonance imaging (MRI) scan 
documenting a herniated nucleus pulposus estimated to 
have less than 50% (those whose herniated nucleus pulposus 
continued after operation were not included in the study 
and those whose operations took place at least three months 
earlier were included) intervertebral foraminal narrowing, or 
manifested clinical signs such as radicular pain and sensory 
or fixed motor deficits consistent with lumbar radiculopathy 
at the MRI-documented lumbosacral root level.
Patients were excluded from the study if they had a large 
herniated nucleus pulposus with severe central or foraminal 
stenosis on MRI, had segmental instability, had progressive 
neurologic deficits, had undergone prior epidural steroid 
injections, had a blood coagulation disorder, or had previously 
experienced an allergic reaction to local anesthetics or steroids. 
Patients who met the inclusion criteria signed an informed con-
sent that described the trial with its risks, benefits, alternatives, 
and objectives as per the institutional review board protocol.
The patients (American Society of Anesthesiologists 
classification I–II, 42 cases, 23 females and 19 males, aged 
25–73 years) were randomly assigned to two treatment 
groups, ie, Group K and Group G. Patients in each group 
were well informed about their disease, and the treatment 
modalities were applied. Furthermore, the patients in both 
groups were asked to keep a private pain diary during this 
research. Each patient was taught how to mark a visual 
analog scale (VAS) and the pain scale values at the given 
time intervals in the diary. Thereby, we had the chance to 
determine correctly when VAS values reached the value 4 
(this is the value when the patients were relieved from pain 
and when the pain did not affect their regular sleep pattern). 
Consequently, this research is a prospective, randomized and 
nonblinded (but not placebo-controlled) research.
All injections were technically and successfully 
administered by the same anesthesiologist (BZ) at the 
epidural space as verified by epidurography. After sterile 
preparation, draping, and local anesthesia, epidural blocks 
were performed, typically at the L3/4 intervertebral space 
with a 20-gauge 3.5 inch (8.89 cm) Touhy needle (B. Braun™ 
Melsungen, Germany) using the loss of resistance to air 
technique. Prior to each injection, 5 cc of contrast medium 
(Omnipaque®) was used to perform an epidurogram so that 
localization of the injection could be confirmed. All patients 
were treated prospectively with epidural injections consisting 
of 80 mg methylprednisolone acetate in 10 mL of 0.125% 
bupivacaine. Lumbar epidural injection was performed in the 
lateral decubitus position. Within 30 minutes of the epidural 
block, all patients reported complete relief of back pain, with 
variable responses for lower extremity pain. At this time, 
there was no sensory anesthesia in the low back area and no 
motor or sensory anesthesia of the lower extremity.
Following epidural application of a single dose of methyl-
prednisolone acetate in the Group K patients, an oral medical 
treatment containing naproxen sodium (1100 mg/day, once 
every 12 hours), tizanidine (12 mg/day, once every 12 hours), 
and vitamin B and C complex was devised and to be applied 
for one month. In Group G, oral gabapentin (1200 mg/day, 
three times a day, every eight hours) was added to the same 
treatment regime.
Pain levels of the informed patients were evaluated using 
VAS for straight leg raise to 45° before, during, and after 
treatment, as well as in the first and third months.Clinical Pharmacology:   Advances and Applications 2010:2 submit your manuscript | www.dovepress.com
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All data were collected in an Excel®  sheet  for 
documentation. For statistical analysis, the program SPSS 
13.0® for Windows (LEAD Technologies Inc., Charlotte, NC) 
was used. The Mann–Whitney U test was used to compare 
the statistical difference between the obtained demographic 
data (age, weight, and height). The Wilcoxon matched-pairs 
test was used to evaluate the statistical difference between 
VAS values, and the Chi-square test was used to determine the 
statistical difference between genders. In all cases, a P value 
less than 0.05 was considered statistically significant.
Results
It was decided that there was not a significant difference 
between the average values of the demographic data 
(P . 0.05, Table 1). It was identified before starting treatment 
that the VAS values of both groups were similar to each other 
(P = 0.142, Table 2). In addition, it was seen that, compared 
with Group K cases (4.50 ± 1.60 day), the pain level in 
Group G cases (for 3.45 ± 1.70 day) regressed earlier (the 
time when VAS was ,4) after the treatment was started 
(P = 0.04). In parallel with this, it was observed during the 
first and third month controls that, compared with Group K, 
VAS values for Group G progressed at a significantly slower 
pace (P = 0.003 for the first month and P = 0.004 for the third 
month, Table 3). During the sixth month when the research 
was completed, it was observed that the VAS values of Group 
G were significantly lower compared with Group K 
(P , 0.001, Table 2).
According to computerized tomography of the lumbar 
area and MRI examinations carried out in the first and 
third month controls, no epidural abscesses, hematoma, or 
osteoporotic changes were observed. On the other hand, no 
side effects, except for slight sedation due to oral gabapentin 
use, were observed in Group G patients.
Discussion
Many discectomy procedures for disc herniation are per-
formed each year. The removal of the disc does not always 
result in pain relief. Discectomy may eliminate the mechanical 
reasons for pain, but a painful inflammatory condition may 
continue in the postoperative period, and the inflammation 
triggered by the surgical procedure can even start the process 
of fibrosis and cause pain later on. Reported failure rates for 
this surgery range from 2% to 20%.21 Patients with low back 
pain in whom discectomy fails to improve pain have been 
categorized in the surgical literature as FBSS. The reported 
frequency of FBSS may range from 1% to 48%.4–9
Definitions for FBSS are difficult to find and appear to 
differ. Wynn Parry has defined FBSS as intractable back pain 
and sciatica in patients who have failed to improve despite 
numerous courses of treatment, including physiotherapy 
and surgery.22 Fan and Chong have defined FBSS as pain 
and functional incapacitation of varying degrees in patients 
following spinal surgery for low back pain.23 Long did not 
define it, but pointed out that it was an imprecise term used 
to categorize a heterogeneous group of patients who share 
only residual symptoms after treatment failure.24 The lack of 
a universally accepted definition for FBSS has made research 
into this syndrome difficult. However, it is clear that central 
to a definition of FBSS are two notions, ie, patients with this 
syndrome have chronic low back pain, and these chronic pain 
patients have had one or more surgeries on their backs which 
have not helped their low back pain.25
Epidural fibrosis is among the most common causes 
of FBSS, and it is often refractory to treatment. The 
pathophysiology of epidural fibrosis is relatively well 
understood. Fibroblasts from damaged erector spinae 
muscles overlying the surgery site follow the extension of the 
postoperative hematoma into the vertebral canal. Causes of 
epidural fibrosis include the surgeon’s manipulation of tissue 
at the time of surgery, bleeding, dural tears, and irritation 
from mechanical instability.19
There are some experiments going on in animals 
concerning, eg, the efficacy of pimecrolimus or amniotic 
Table 1 Demographic information of the patients
Age (years) Sex (M/F) Weight (kg) Tall (cm)
group K 42.10 ± 12.75 9/12 72.55 ± 14.98 164.10 ± 14.59
group g 47.60 ± 14.61 10/11 68.15 ± 12.67 158.80 ± 13.45
P 0.183 .0.05 0.369 0.327
Table 2 Comparison of the patients’ visual analog score values 
(mean ± standard deviation) before and after treatment (with 
straight leg raising test, 45° angle)
Group K Group G P
VAs Pretreatment 7.70 ± 0.47  8.05 ± 0.69 0.142
end of treatment 
(six months later)
5.60 ± 0.60 2.20 ± 1.28 ,0.001
P ,0.05 ,0.001
Table 3 Comparison of the patients’ visual analog score values 
in  the  first  and  third  months  (with  straight  leg  raising  test, 
45° angle)
Group K Group G P
VAs One month later 1.70 ± 0.47  0.90 ± 0.92 0.003
Three months later 2.15 ± 0.37 1.50 ± 0.76 0.004Clinical Pharmacology:   Advances and Applications 2010:2 submit your manuscript | www.dovepress.com
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membrane in alleviating or preventing epidural adhesions that 
occur following laminectomy.26,27 On the other hand, many 
biologic (such as fibrin glue) and nonbiologic materials (such 
as methylprednisolone acetate) have been tried in a quest to 
prevent epidural fibrosis.28 Spinal endoscopic adhesiolysis 
may be used as an effective treatment modality for chronic 
refractory low back pain and radiculopathy that is related 
to epidural adhesions.29 Moreover, there is a pilot study 
which shows that the use of a Vaseline®-sterile oil-morphine 
compound is effective in preventing postoperative pain and 
postoperative adhesion after lumbar microdiscectomy.30 
However, inducing the least amount of injury to the anatomy 
of the tissues and very good hemostasis seem to be the most 
effective methods in the prevention of epidural fibrosis.28
Epidural steroid injections are an accepted treatment for 
low back pain with a radicular component secondary to lum-
bar disc pathology or spinal stenosis.31 Traditional epidural 
injection routes are dorsal, and corticosteroid spread to the 
ventral target site occurs by diffusion. Additionally, the dorsal 
median epidural septum may confine the spread of dorsal 
epidural flow to the side ipsilateral to the injection.32 The 
mechanism of therapeutic benefit is attributed to relieving 
the inflammation secondary to mechanical and/or chemical 
nerve root irritation.31
Epidural steroid application in patients who receive 
  anticoagulant treatments or who have local anesthetic aller-
gies, skin infections, central nerve system disorders, diabetes, 
intestinal and bladder disorders, congestive cardiac failure, 
or exogenous steroid application restrictions is contraindicat-
ed.33 Other complications connected with dural penetration, 
such as headache, nausea, vomiting, steroid myopathy, arach-
noiditis, meningitis, water-salt retention, and vision loss, have 
also been reported.34 Fluoroscopic guidance and contrast 
confirmation allows confident placement of the steroid within 
the epidural space, avoiding inadvertent intrathecal or intra-
vascular injection. We use a stationary C-arm fluoroscope 
and believe that the interlaminar lumbar approach requires 
the ability to image in both frontal and lateral planes. On 
the other hand, Fredman et al reported that the resistance 
loss technique is a safe indicator in determining the lumbar 
epidural intervals in patients with FBSS,35 and we have also 
applied this technique successfully in all our patients.
Surgical injury results in acute nociception, as well as 
sensitization of the dorsal horn of the spinal cord, which can 
lead to hyperalgesia and allodynia.36 During laminectomy 
and discectomy, there is trauma to the soft tissues and bony 
structures, which can result in severe pain at rest as well as 
during movement. There may be an additional component 
of neuropathic pain due to nerve root compression. Even 
though gabapentin has no antinociceptive effects, it has been 
shown in animal experiments that it has both antiallodynic 
and antihyperalgesic effects.37 The anticonvulsant gabapentin 
has an affinity to voltage-dependent calcium channels and 
amino acid transfer, and modulates the release of excitatory 
amino acids at the level of the dorsal horn of the spinal cord. 
It reduces dorsal horn responses to fiber input and blocks 
ectopic discharges from injured nerves.38,39 Gabapentin was 
initially reported to be effective in treating different types 
of neuropathic pain.40 Rosenberg et al also performed a ret-
rospective study of gabapentin for use in neuropathic pain 
and low back pain.41 The fact that we have shown a similar 
result to that of Braverman et al10 in our patients, who were 
radiologically proven to have epidural fibrosis, indicates 
that gabapentin might be an effective alternative treatment 
for FBSS.
On the other hand, the psychosocial status of cases is 
regarded as a risk factor for development of FBSS.25 In 
our study, we did not have the opportunity to investigate 
psychosocial status in our patients, and this may limit the 
results we obtained. However, addition of gabapentin to 
epidural corticosteroid application achieved a significant 
reduction in pain scores.
Conclusion
FBSS, most commonly caused by epidural fibrosis, represents 
an extremely difficult clinical problem, made more complex 
by the multidimensional nature of pain itself. Epidural 
corticosteroids, because of their anti-inflammatory properties, 
have been the cornerstone of treatment. The mainstay of 
management of recalcitrant symptomatic epidural fibrosis at 
this time is pharmacologic intervention. In our research, we 
identified that addition of gabapentin to epidural corticoster-
oid application is helpful in reducing pain in FBSS.
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